Development of cap-dependent endonuclease inhibitors for bunyaviruses
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00430
- Awardee
-
Medchemexpress LLC UEI EWMQQNKJ3YZ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,365
Award facts
- Contract value 100% obligated
- $18,365.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$3,700 | |
| Original award | $22,065 |
About this award
Medchemexpress LLC has been awarded a $18,365 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to support the development of cap-dependent endonuclease inhibitors for bunyaviruses. Per the award description, Medchemexpress will provide chemical compounds and research materials to support the agency's biomedical research program aimed at developing inhibitors for this class of viruses. As a foreign owned, minority owned, self-certified small disadvantaged business, Medchemexpress has extensive experience providing biochemicals, bioactive compounds and other life science research materials to NIH and its components under previous contracts ranging from $11,035 to $235,092. The current award carries no set aside designation.
Quick answers
Who was awarded contract 75N95023P00430?
75N95023P00430 was awarded to Medchemexpress LLC by National Institute on Drug Abuse (National Institutes of Health) on July 17, 2023.
How much is contract 75N95023P00430 worth?
The government has obligated $18,365 on 75N95023P00430.
Which agency awarded contract 75N95023P00430?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00430, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00430 competed?
The extent of competition for 75N95023P00430 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award